BR9806212A - Composições farmacêuticas sólidas compreendendo uma ciclosporina e um surfactante aniÈnico. - Google Patents

Composições farmacêuticas sólidas compreendendo uma ciclosporina e um surfactante aniÈnico.

Info

Publication number
BR9806212A
BR9806212A BR9806212-3A BR9806212A BR9806212A BR 9806212 A BR9806212 A BR 9806212A BR 9806212 A BR9806212 A BR 9806212A BR 9806212 A BR9806212 A BR 9806212A
Authority
BR
Brazil
Prior art keywords
anionic surfactant
solid pharmaceutical
cyclosporine
pharmaceutical compositions
cyclosporin
Prior art date
Application number
BR9806212-3A
Other languages
English (en)
Inventor
Bernard Charles Sherman
Original Assignee
Bernard Charles Sherman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bernard Charles Sherman filed Critical Bernard Charles Sherman
Publication of BR9806212A publication Critical patent/BR9806212A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçõES FARMACêUTICAS SóLIDAS COMPREENDENDO UMA CICLOSPORINA E UM SURFACTANTE ANIÈNICO". Uma composição farmacêutica sólida para administração oral compreendendo uma ciclosporina e um surfactante aniónico, preferencialmente lauril sulfato de sódio.
BR9806212-3A 1997-09-16 1998-09-16 Composições farmacêuticas sólidas compreendendo uma ciclosporina e um surfactante aniÈnico. BR9806212A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ328751A NZ328751A (en) 1997-09-16 1997-09-16 Solid medicament containing an anionic surfactant and cyclosporin
PCT/CA1998/000880 WO1999013900A1 (en) 1997-09-16 1998-09-16 Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant

Publications (1)

Publication Number Publication Date
BR9806212A true BR9806212A (pt) 2000-04-18

Family

ID=19926445

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9806212-3A BR9806212A (pt) 1997-09-16 1998-09-16 Composições farmacêuticas sólidas compreendendo uma ciclosporina e um surfactante aniÈnico.

Country Status (23)

Country Link
US (1) US6197335B1 (pt)
EP (1) EP0957931B1 (pt)
JP (1) JP2001505928A (pt)
KR (1) KR20000068991A (pt)
CN (1) CN1239432A (pt)
AR (1) AR013499A1 (pt)
AT (1) ATE214938T1 (pt)
AU (1) AU9149198A (pt)
BR (1) BR9806212A (pt)
CA (1) CA2271447A1 (pt)
CZ (1) CZ157099A3 (pt)
DE (1) DE69804429D1 (pt)
HU (1) HUP0000839A3 (pt)
ID (1) ID21683A (pt)
IL (1) IL129780A0 (pt)
NO (1) NO992340L (pt)
NZ (1) NZ328751A (pt)
PL (1) PL333353A1 (pt)
SI (1) SI9820010A (pt)
TR (1) TR199901070T1 (pt)
WO (1) WO1999013900A1 (pt)
YU (1) YU22399A (pt)
ZA (1) ZA988452B (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US7732404B2 (en) * 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB0008785D0 (en) * 2000-04-10 2000-05-31 Novartis Ag Organic compounds
AR033711A1 (es) * 2001-05-09 2004-01-07 Novartis Ag Composiciones farmaceuticas
WO2003032949A1 (en) * 2001-10-19 2003-04-24 Isotechnika Inc. Novel cyclosporin analog microemulsion preconcentrates
US20100022414A1 (en) 2008-07-18 2010-01-28 Raindance Technologies, Inc. Droplet Libraries
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
JP4521554B2 (ja) * 2004-03-31 2010-08-11 マイラン製薬株式会社 シクロスポリン製剤
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
US20070015691A1 (en) 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7288520B2 (en) 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US7276476B2 (en) * 2005-07-13 2007-10-02 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US20070015693A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) * 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
EP3913375A1 (en) 2006-01-11 2021-11-24 Bio-Rad Laboratories, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP2481815B1 (en) 2006-05-11 2016-01-27 Raindance Technologies, Inc. Microfluidic devices
WO2008021123A1 (en) 2006-08-07 2008-02-21 President And Fellows Of Harvard College Fluorocarbon emulsion stabilizing surfactants
WO2008097559A2 (en) 2007-02-06 2008-08-14 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
SG2013054218A (en) 2008-01-15 2014-10-30 Abbott Gmbh & Co Kg Powdered protein compositions and methods of making same
EP2262477A1 (en) * 2008-03-04 2010-12-22 F. Hoffmann-La Roche AG Process for preparing concentrated aqueous micellar solutions
US8528589B2 (en) 2009-03-23 2013-09-10 Raindance Technologies, Inc. Manipulation of microfluidic droplets
WO2011042564A1 (en) 2009-10-09 2011-04-14 Universite De Strasbourg Labelled silica-based nanomaterial with enhanced properties and uses thereof
WO2011079176A2 (en) 2009-12-23 2011-06-30 Raindance Technologies, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
JP5934657B2 (ja) 2010-02-12 2016-06-15 レインダンス テクノロジーズ， インコーポレイテッド デジタル検体分析
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
EP2622103B2 (en) 2010-09-30 2022-11-16 Bio-Rad Laboratories, Inc. Sandwich assays in droplets
EP3859011A1 (en) 2011-02-11 2021-08-04 Bio-Rad Laboratories, Inc. Methods for forming mixed droplets
WO2012112804A1 (en) 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions and methods for molecular labeling
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
EP3709018A1 (en) 2011-06-02 2020-09-16 Bio-Rad Laboratories, Inc. Microfluidic apparatus for identifying components of a chemical reaction
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
WO2015103367A1 (en) 2013-12-31 2015-07-09 Raindance Technologies, Inc. System and method for detection of rna species
EP3091974B1 (en) * 2014-01-06 2020-04-01 Shield TX (UK) Limited Dosage regimen of ferric trimaltol
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
WO2019181876A1 (ja) * 2018-03-19 2019-09-26 大鵬薬品工業株式会社 アルキル硫酸ナトリウムを含む医薬組成物
TW202330014A (zh) * 2021-10-13 2023-08-01 日商中外製藥股份有限公司 含有胜肽化合物及界面活性劑之組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7908722A (nl) 1979-12-03 1981-07-01 Naarden International Nv Werkwijze voor de bereiding van citrussap bevattende dranken met verbeterde troebelingsstabiliteit.
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JP2577049B2 (ja) 1987-06-04 1997-01-29 三共株式会社 シクロスポリン製剤
US5756450A (en) * 1987-09-15 1998-05-26 Novartis Corporation Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
US5342625A (en) 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
FR2642650B1 (fr) * 1989-02-09 1994-12-09 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines
DD298351A5 (de) * 1989-11-06 1992-02-20 Jenapharm Gmbh,De Verfahren zur herstellung einer carrierabhaengigen arzneiform
JPH0597697A (ja) * 1991-10-02 1993-04-20 Lion Corp 歯槽骨再生剤
US5603955A (en) * 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
IL139728A (en) * 1995-01-09 2003-06-24 Penwest Pharmaceuticals Compan Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
US5573783A (en) * 1995-02-13 1996-11-12 Nano Systems L.L.C. Redispersible nanoparticulate film matrices with protective overcoats
IE75744B1 (en) * 1995-04-03 1997-09-24 Elan Corp Plc Controlled release biodegradable micro- and nanospheres containing cyclosporin
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
JPH1059862A (ja) * 1996-08-16 1998-03-03 Meiji Seika Kaisha Ltd シクロスポリン製剤
US5891845A (en) * 1997-11-21 1999-04-06 Fuisz Technologies Ltd. Drug delivery systems utilizing liquid crystal structures

Also Published As

Publication number Publication date
NZ328751A (en) 1999-01-28
NO992340L (no) 1999-07-06
ATE214938T1 (de) 2002-04-15
JP2001505928A (ja) 2001-05-08
CA2271447A1 (en) 1999-03-25
IL129780A0 (en) 2000-02-29
HUP0000839A3 (en) 2001-02-28
US6197335B1 (en) 2001-03-06
PL333353A1 (en) 1999-12-06
TR199901070T1 (xx) 1999-11-22
AR013499A1 (es) 2000-12-27
SI9820010A (sl) 1999-08-31
ID21683A (id) 1999-07-08
KR20000068991A (ko) 2000-11-25
YU22399A (sh) 2003-01-31
CZ157099A3 (cs) 1999-09-15
ZA988452B (en) 1999-03-30
HUP0000839A2 (hu) 2000-11-28
EP0957931B1 (en) 2002-03-27
EP0957931A1 (en) 1999-11-24
CN1239432A (zh) 1999-12-22
DE69804429D1 (de) 2002-05-02
WO1999013900A1 (en) 1999-03-25
NO992340D0 (no) 1999-05-14
AU9149198A (en) 1999-04-05

Similar Documents

Publication Publication Date Title
BR9806212A (pt) Composições farmacêuticas sólidas compreendendo uma ciclosporina e um surfactante aniÈnico.
BR9914251A (pt) Formulações orais de liberação sustentada
BR9810495A (pt) Composição farmacêutica
TR200002299T2 (tr) Epotilon kompozisyonları.
BG106030A (en) Pharmaceutical composition
BR9611802A (pt) Composições farmacêuticas
BR0012908A (pt) Método para preparar uma composição oral estável antibacteriana contendo uma lupulona hidrogenada, e, composição oral estável antibacteriana
PL345955A1 (en) PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
BR9807383A (pt) Formulação farmacêutica que compreende amoxicilina e clavulanato
DZ2509A1 (fr) Analogues peptidiques de la lh-rh leur utilisationet les compositions pharmaceutiques les contenant.
MX9505065A (es) Composicion farmaceutica, aplicable oralmente.
BR0008228A (pt) Composições de n-benzoil estaurosporinaespontaneamente dispersìveis
MX9505064A (es) Composicion farmaceutica, aplicable oralmente.
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
DE10084671T1 (de) Pharmazeutische Zusammensetzungen
NZ511085A (en) Oral pharmaceutical compositions containing buprenorphin
PL348419A1 (en) Sustained-release pharmaceutical preparation containing tilidine mesylate as active ingredient
DE69917796D1 (de) Decursin-enthaltende pharmazeutische zusammensetzungen
TR200000291T2 (tr) Taşikinin reseptör antagonistleri olarak 2-asilaminopropanaminler.
PT1066304E (pt) Antagonistas macrolidos de lhrh
NZ506622A (en) 3',3'-N-bis-substituted macrolide LHRH antagonists
ES2150404T3 (es) Composiciones farmaceuticas de tizoxanida y nitozoxanida.
GEP20043377B (en) Pharmaceutical Complex
EP0937708A3 (en) sulphonamide derivatives
TR200002293T2 (tr) Farmasötik bileşimler.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]